Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen
- 29 January 1981
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 304 (5), 251-258
- https://doi.org/10.1056/nejm198101293040502
Abstract
We studied the effect of the bile acid sequestrant colestipol, alone and in combination with clofibrate or niacin, in patients with heterozygous familial hypercholesterolemia who were given a diet low in cholesterol and saturated fat.This publication has 36 references indexed in Scilit:
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980
- Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A MetabolismJournal of Clinical Investigation, 1979
- Failure of Complete Bile Diversion and Oral Bile Acid Therapy in the Treatment of Homozygous Familial HypercholesterolemiaNew England Journal of Medicine, 1977
- The effect of cholestyramine on the faecal excretion of bile acids and neutral steroids in familial hypercholesterolaemiaAtherosclerosis, 1977
- Coronary Artery Disease in 116 Kindred with Familial Type II HyperlipoproteinemiaCirculation, 1974
- The Effects of Colestipol Resin and of Colestipol Plus Clofibrate on the Turnover of Plasma Cholesterol in ManJournal of Clinical Investigation, 1973
- EFFECTS AND SIDE‐EFFECTS OF TREATMENT OF HYPERCHOLESTEROLEMIA WITH CHOLESTYRAMINE AND NEOMYCINActa Medica Scandinavica, 1973
- Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous formAtherosclerosis, 1971
- Reduction of Serum Cholesterol and Triglyceride Levels by the Combined Administration of Neomycin and ClofibrateCirculation, 1970
- Coronary Disease in Familial HypercholesterolemiaCirculation, 1967